Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 19 | 20 | +1 |
| Shares | 1.39M | 1.39M | −3.63K (−0.3%) |
| Value | $691.4K | $349.8K | −$341.6K (−49.4%) |
New holders (4)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 19,346 | $4.00K | 0.00% |
| UBS Group AG | 707 | $177 | 0.00% |
| JPMorgan Chase & Co | 20 | $5 | 0.00% |
| Macroview Investment Management LLC | 12 | $3 | 0.00% |
Sold out (3)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 28,108 | $14.0K |
| Verdence Capital Advisors LLC | 20,012 | $9.96K |
| Two Sigma Securities, LLC | 10,700 | $5.32K |